scispace - formally typeset
N

Narayan Prasad Parajuli

Researcher at Manmohan Memorial Institute of Health Sciences

Publications -  23
Citations -  518

Narayan Prasad Parajuli is an academic researcher from Manmohan Memorial Institute of Health Sciences. The author has contributed to research in topics: Drug resistance & Antibiotic resistance. The author has an hindex of 12, co-authored 22 publications receiving 385 citations. Previous affiliations of Narayan Prasad Parajuli include Kathmandu & Tribhuvan University.

Papers
More filters
Journal ArticleDOI

High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal.

TL;DR: Alarming rate of drug resistance among pediatric uropathogens and high rate of ESBL-producing E. coli was observed and it is extremely necessary to routinely investigate the drug resistanceamong all isolates and formulate strict antibiotics prescription policy in this country.
Journal ArticleDOI

High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal

TL;DR: Investigation of the spectrum and antimicrobial resistance of bacterial isolates involved in healthcare associated infections in the patients of a critical care unit at a tertiary care university hospital in Kathmandu, Nepal finds alarming state of drug resistance among these isolates.
Journal ArticleDOI

Elevated Cardiovascular Risks among Postmenopausal Women: A Community Based Case Control Study from Nepal.

TL;DR: Since more of the atherogenic lipid parameters are increased in postmenopausal women, they appear to be more prone to have CVD and associated complications in near future, it is mandatory to monitor and manage dyslipidemic pattern in every woman experiencing menopause.
Journal ArticleDOI

Extended-Spectrum β-Lactamase (ESBL) Genotypes among Multidrug-Resistant Uropathogenic Escherichia coli Clinical Isolates from a Teaching Hospital of Nepal.

TL;DR: It is indicated that the high rates of multidrug-resistant Escherichia coli are frequent causes of UTI in a tertiary care teaching hospital of Nepal and Nitrofurantoin and aminoglycosides are the most useful first-line drugs to be used in the cases ofUTI.